
==== Front
Nucleic Acids ResNucleic Acids ResnarnarNucleic Acids Research0305-10481362-4962Oxford University Press 1762604910.1093/nar/gkm486Methods OnlineEngineered apoptotic nucleases for chromatin research Xiao Fei 1Widlak Piotr 12Garrard William T. 1*1Department of Molecular Biology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA and 2Faculty of Biotechnology, University of Rzeszow, 36-100 Werynia, Poland*To whom correspondence should be addressed. +1 214 648 1924+1 214 648 1915william.garrard@utsouthwestern.edu7 2007 10 7 2007 10 7 2007 35 13 e93 e93 18 4 2007 28 5 2007 5 6 2007 © 2007 The Author(s)2007This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.We have created new genomics tools for chromatin research by genetically engineering the human and mouse major apoptotic nucleases that are responsible for internucleosomal DNA cleavage, DNA fragmentation factor (DFF). Normally, in its inactive form, DFF is a heterodimer composed of a 45-kDa chaperone inhibitor subunit (DFF45 or ICAD), and a 40-kDa latent endonuclease subunit (DFF40 or CAD). Upon caspase-3 cleavage of DFF45, DFF40 forms active endonuclease homo-oligomers. Although Saccharomyces cerevisiae lacks DFF, expression of caspase-3 is lethal in this organism, but expression of the highly sequence-specific tobacco etch virus protease (TEVP) is harmless. Therefore, we inserted TEVP cleavage sites immediately downstream of the two caspase-3 cleavage sites within DFF45, generating a novel form of DFF (DFF-T) whose nuclease activity proved to be exclusively under the control of TEVP. We demonstrate that co-expression of TEVP and DFF-T under galactose control results in nucleosomal DNA laddering and cell death in S. cerevisiae. We also created synthetic DFF genes with optimized codons for high-level expression in Eschericia coli or S. cerevisiae. We further demonstrate the excellence of the synthetic gene products for in vitro mapping of the nucleosome positions and hypersensitive sites in specific genes such as the yeast PHO5.
==== Body
INTRODUCTION
Eukaryotic genomic DNA is organized into repeating arrays of nucleosomes that are the structural units of chromatin (1). The nucleosome is also known to play a central role in regulating gene transcription from promoters (2). For more than 30 years, micrococcal nuclease (MNase), DNase I and restriction endonucleases have been essential tools for chromatin research (1). MNase in particular has been the gold standard for characterizing nucleosomal structures in chromatin, because of its relative high specificity toward the internucleosomal linker region. However, this enzyme also digests DNA within nucleosome core particles, attacks single-stranded nucleic acids, possesses exonuclease activity and has significant DNA sequence cleavage preferences (3–5).

One of the hallmarks of the terminal stages of programmed cell death or apoptosis is internucleosomal DNA breakdown (6). The endonuclease primarily responsible for mediating apoptotic nucleosomal DNA laddering is DNA fragmentation factor-40 (DFF40), also called caspase-activated deoxyribonuclease (CAD) (7–10). DFF is a heterodimer in its inactive form, composed of a 45-kDa inhibitor and chaperone subunit (DFF45), also called inhibitor of CAD (ICAD), and a 40-kDa latent endonuclease subunit (DFF40/CAD) (7–13). This protein complex possesses nuclear localization sequences and resides within the cell nucleus (9,14–16). Caspase-3 or -7 cleavage of DFF specifically cuts only DFF45, releasing DFF40 from the complex, which in turn forms enzymatically active homo-oligomers (11–13,17,18).

During the course of our studies on characterizing the enzymatic properties of DFF40 on chromatin substrates, we recognized its potential as an excellent reagent for chromatin research because of its exquisite selectivity for linker region cleavage, its exclusive generation of double-stranded breaks and lack of both exonuclease activity and attack within nucleosome core particles (10,13,19–23). Indeed, evolutionary pressure to create ‘bite-size’ pieces of chromatin for phagocytotic clearance of apoptotic products appears to have optimized DFF40 to specifically attack the linker regions in polynucleosomal chains. However, DFF's nuclease dependency on caspase-3, which has numerous other cellular protein substrates (24), in combination with the protease's high cost, limits DFF's potential for chromatin studies. We therefore decided to engineer DFF nuclease activity to be dependent on TEVP cleavage (DFF-T) because this protease has a seven amino acid recognition cleavage sequence instead of the less stringent four amino acid target sequence of caspase-3 (24,25). Importantly, caspase-3 expression in yeast is lethal, but expression of the highly sequence-specific TEVP is harmless (26–28). Thus, TEVP expression per se should not cause any artificial alterations in chromatin structure and gene expression.

We demonstrate here the successful expression of recombinant forms of these proteins in either Eschericia coli or Saccharomyces cerevisiae and that after TEVP cleavage highly active DFF endonuclease is generated. We further demonstrate that DFF-T is an excellent reagent for mapping nucleosome positions and hypersensitive sites in specific genes as revealed by chromatin footprinting of the well-studied PHO5 gene, whose promoter and upstream region displaces four nucleosomes upon transcriptional induction via chromatin remodeling and binding of Pho4p (29–33).

MATERIALS AND METHODS
Generation of mouse or human DFF nuclease activities dependent on TEVP cleavage by mutagenesis and expression in E. coli
The TEVP cut site (25), encoding the amino acid sequence ENLYFQS, was inserted between amino acid positions 117–118 and 224–225, immediately downstream of each of the two caspase-3 cleavage sites in the coding sequence of mouse DFF45. We created all three possible combinations of these insertion mutations, termed I1WT, WTI2 and I1I2. Similarly, we created the corresponding I1I2 human DFF45 species, and also substituted the caspase-3 cleavage sites with TEVP cut sites in all combinations in mouse DFF45. Using the two-plasmid E. coli expression system for DFF (34) kindly provided by Gregor Meiss, the individual modified forms of mouse DFF45 along with the corresponding wild-type control were co-expressed with mouse GST-DFF40. The resulting GST-fusion protein-containing complexes were purified on GSH-Sepharose. Human DFF species were cloned into pRSFDuet™ for co-expression in E. coli (Novagen) and purification by nickel chromatography.

Assay of DFF45 cleavage and DFF40 endonuclease activity on plasmid DNA substrate
Recombinant caspase-3 was prepared as previously described (9), and TEVP was purchased from Invitrogen. One microgram of either wild-type, swap or insertion mutated DFF40/DFF45 heterodimer were incubated with caspase-3 or 0.5 unit of TEVP at 37°C in reaction buffer consisting of 10 mM KCl, 100 mM NaCl, 1.5 mM MgCl2, 1 mM EGTA, 1 mM dithiothreitol and 20 mM Tris–Cl, pH 7.5. After 20 min of incubation, samples were separated on 12% polyacrylamide–SDS gels, and then proteins were electrophoretically transferred onto nitrocellulose membranes. Membrane-immoblilized proteins were probed with the following commercial antibodies: rabbit anti-human DFF40 polyclonal antibodies and/or rabbit anti-human DFF45 N-terminus polyclonal antibodies (Pharmingen). The antigen–antibody complexes were visualized using enhanced chemiluminescence (ECL) western blotting detection reagents (Amersham Biosciences). For the endonuclease activity assay, 1 μg of naked plasmid DNA was incubated for 30 min at 37°C with DFF nuclease species pre-incubated with appropriate protease, as indicated in the legends of Figure 1. Aliquots of the endonuclease reaction were stopped by gel loading buffer containing 0.6% SDS, 50 mM EDTA, 30% glycerol and samples were then separated on 1.5% agarose gels using TAE as the running buffer. After electrophoresis, DNA was stained with ethidium bromide, and gels were scanned with a FluorImager (Molecular Dynamics Inc., Sunnyvale, CA, USA).
Figure 1. Inserting TEVP cleavage sites downstream of caspase-3 cleavage sites within DFF45 is effective in generating DFF40 nuclease activity to be dependent on TEVP cleavage. (A and D) Amino acid sequence of mouse DFF45 (fragments containing both protease cleavage sites). The caspase-3 recognition sequences are underlined, the TEVP recognition sequences are in italics. (B and E) The indicated forms of mouse DFF heterodimers, either wild-type (WT), swap (S) or insertion (I) mutants, were expressed in E. coli, purified and treated either with caspase-3, TEVP, both or neither. Western blot of a SDS–PAGE gel probed with anti-DFF45 antibodies (B) or with a mixture of anti-DFF40 and anti-DFF45 antibodies (E); arrowheads mark the positions of intact DFF45 and GST-DFF40. (C and F) Agarose gel of plasmid DNA substrate incubated with the indicated proteinase-treated DFF species, either wild-type (WT), swap (S) or insertion (I) mutants.



Expression of mouse DFF-T and TEVP in S. cerevisiae
The TEVP gene's coding region with SV40 nuclear localization signals added to its N- and C-termini, under the control of the GAL1 promoter, and cloned into a TRP1 integration vector (28), which was kindly provided by Kim Nasmyth and used to stably transform the yeast P2 strain (35). DFF40 and wild-type DFF45 or the other three insertion mutants, I1WT, WTI2 and I1I2, were cloned into pESC-His dual yeast expression vector (Novagen) containing two divergently orientated galactose inducible GAL1 and GAL10 promoters. The pESC-DFF vectors were introduced into yeast P2 strains containing or lacking integrated TEVP via standard lithium acetate transformation and selection on synthetic complete medium lacking histidine and tryptophan, supplemented with 2% dextrose. To assay the effects of TEVP and DFF expression on cell viability, exponentially growing cultures of individual transformants were serially diluted 10-fold in 10 mM Tris–HCl (pH 8.0), 1 mM EDTA and 5 μl aliquots were spotted onto selective media supplemented with 2% raffinose and 2% galactose. The number of viable cells forming colonies at 30°C was determined. For in vivo endonuclease activity assay, yeast genomic DNA was isolated and analyzed. Briefly, 10 ml cultures of yeast cells transformed as indicated in Figure 2A, were harvested by centrifugation following galactose induction for 6 h. The cells were washed with 1 ml of distilled H2O, re-suspended in 200 μl of 2% Triton X-100, 1% SDS, 100 mM NaCl, 10 mM Tris–Cl, pH 8.0, 1 mM EDTA, pH 8.0, vortexed at highest speed for 3 min with 200 μl glass beads and 200 μl phenol/chloroform/isoamyl alcohol, followed by the addition of 200 μl TE buffer and centrifugation for 5 min. The genomic DNA in the aqueous layer was ethanol precipitated and re-suspended and treated with 100 μg/ml RNase for 20 min at 37°C. The DNA was phenol extracted, ethanol precipitated and re-suspended in 50 μl TE buffer. The integrity of 5 μg DNA samples was assessed by agarose gel electrophoresis.
Figure 2. Expression of DFF-T in yeast. (A) Co-expression of TEVP, GST-DFF40 and the TEVP-cleavable DFF45 I1I2, is lethal in yeast cells. Suspended yeast cells with or without an integrated TEVP gene and harboring the indicated forms of mouse DFF in a yeast expression plasmid were serially diluted 10-fold, and 5 μl aliquots were spotted onto galactose plates. Plates were photographed after 3 days of growth at 30°C. (B) Nucleosomal DNA laddering in vivo in yeast requires the combined expression of TEVP, GST-DFF40 and the DFF45 I1I2 mutant. Agarose gel of genomic DNA purified from yeast harboring the indicated forms of mouse DFF in a yeast expression plasmid after 6 h of galactose induction.



Generation of synthetic genes for high-level expression of DFF in E. coli
We took advantage of the ‘Center for Invention’ resource at UT Southwestern to generate a computer-assisted prediction for the design of synthetic genes and their robotic synthesis from pairs of overlapping 40-mer oligonucleotides (36). We have created, through this core, synthetic genes for both mouse and human forms of DFF40 and DFF45. After ligation of oligonucleotides, we amplified the products with high-fidelity PCR in preparation for cloning and sequencing. Any mutations that occurred were cured by additional high-fidelity PCR reactions with appropriate primers and repeated subcloning and sequencing. We have designed these synthetic genes to possess hexa-his tags at the C-terminal ends of DFF40 species, to either lack or possess the TEVP-cut sites as described below (sequences will be made available upon request), as well as the appropriate restriction sites for cloning into pRSFDuet™ E. coli expression vectors (Novagen). Eschericia coli BL21(DE3) cells transformed with this plasmid were induced with 0.5 mM IPTG for 3 h when the optical density at a wavelength of 600 nm (OD600) was 0.5. Cells were lysed by thawing in wash buffer solution (WB; 50 mM NaH2PO4, 300 mM NaCl containing lysozyme (1 mg/ml), RNase A (10 μg/ml) and DNaseI (5 μg/ml). Lysates were clarified by centrifugation and allowed to bind to nickel affinity resin (Ni-NTA superflow, Qiagen) for 1 h at 4°C with gentle mixing. After washing with WB, the protein was eluted with elution buffer solution (10 mM NaH2PO4, 100 mM NaCl, pH 8.0, 250 mM imidazole).

Mapping nucleosome positions on the inactive and induced PHO5 gene's upstream and coding regions
Saccharomyces cerevisiae strain W303 was grown over night at 30°C in yeast nitrogen base phosphate-free medium. Cells were centrifuged, suspended in fresh medium, either phosphate-free or supplemented with 14 mM KH2PO4 and grown for an additional 9 h. Cells were centrifuged and washed with water. One g of wet cell pellet was suspended in 2 ml of yeast lysis buffer (1 M sorbitol, 5 mM β-mecaptoethanol supplemented with 2 mg/ml of Zymolase 100T, ICN) and incubated at room temperature for 3–4 min with occasional agitation in 2-ml round-bottom microcentrifuge tubes. Cells were centrifuged for 15 s, washed in 1 M sorbitol, then suspended in 4 ml of digestion buffer (1 M sorbitol, 50 mM NaCl, 10 mM Tris–Cl pH 7.6, 5 mM MgCl2, 1 mM CaCl2, 1 mM β-mecaptoethanol, 0.5 mM spermidine, 0.075% NP-40) supplemented with 2 μg/ml of RNaseA and incubated for 15 min at room temperature (DFF is inhibited by RNA) (37). Aliquots measuring 400 μl of the resulting suspension were mixed with 100 μl of MNase (Worthington, 1 or 2 U) in digestion buffer. Alternatively, 400 μl aliquots of the resulting suspension were diluted with 400 μl of digestion buffer and mixed with 500 μl solution of TEVP-activated human DFF-T (100 or 200 pmol) in digestion buffer (100 pmol of DFF-T was pre-incubated with 50 U of AcTEV protease for 15 min at room temperature). Digestion mixtures were incubated for 10 min at 33°C, and then reactions were stopped by adding 1/5 vol of stop solution (2% SDS, 100 mM EDTA and 2 mg/ml proteinase K). Mixtures were incubated for 6 h at 50°C and for additional 4 h at 65°C, then phenol/chlorophorm extracted and isopropanol precipitated. DNA was purified by routine RNaseA treatment, phenol/chlorophorm extractions and isopropanol precipitation. DNA concentration was assessed by fluorometry; usually ∼25 μg of DNA was recovered from 0.1 g of wet yeast cell pellet. Ten micrograms of purified DNA was digested with ApaI restriction enzyme (50 U for 15 h at 28°C), electrophorectically separated on a 1.6% agarose gel and transferred onto Zeta-probe (Bio-Rad) nylon membrane using alkali (0.4 M NaOH, 1.5 M NaCl). The membrane was pre-hybridized for 4 h at 64°C with 0.5 M sodium phosphate (pH 7.2), 7% SDS, 1 mM EDTA and then hybridized over night in the same buffer supplemented with 0.1 mg/ml of denatured calf thymus DNA and 10 ng/ml of 32P-labeled PCR-amplified PHO5 probe, which was a 200-bp fragment adjacent to the ApaI site generated with the following primers 5′-GTC TTC AGC GTC AAC TTT AG-3′ and 5′-TAA CGA TGA TGG TCC CTT AA-3′ (32).

RESULTS AND DISCUSSION
Generation of TEVP-cleavage-dependent DFF nuclease activity
In an attempt to convert mouse DFF's nuclease activity to be dependent on TEVP cleavage, we first swapped one or both of the caspase-3 cleavage sites within DFF45 with a TEVP recognition sequence (Figure 1A). After co-expression of the different recombinant forms of DFF in E. coli and purification of the heterodimers, we separately assayed the cleavage pattern of DFF45 mutant forms by either caspase-3 or TEVP (or both) via western blotting, and the activity of DFF40 nuclease by digestion of a plasmid DNA substrate. As shown in Figure 1B, the various forms of DFF45 were cleaved as expected by the appropriate proteases. However, in spite of the fact that the double swap mutant was effectively cleaved by TEVP (Figure 1B, lane 12), DFF40 nuclease activity was only weakly generated compared with the wild-type control after cleavage by caspase-3 ± TEVP (Figure 1C, compare lanes 8 and 12 with 9). Interestingly, the S1WT but not the WTS2 mutant was also fully activated after cleavage by both proteases (Figure 1C, compare lanes 10 and 11). It therefore appears as if maintenance of the second caspase-3 cleavage site is most important for maintaining DFF45 chaperone function. We conclude that the swapped amino acid sequence at caspase-3 cleavage sites within DFF45 apparently plays a chaperone role in folding DFF40 into a potential nuclease capable of activation.

Because the caspase-3 sites within DFF45 are important for its chaperone activity, we created another series of DFF45 mutants in which the TEVP cleavage sequence was inserted immediately downstream of the caspase-3 cleavage sites (Figure 1D). Surprisingly, even though the caspase-3 recognition sequences DEPD and DAVD in mouse DFF45 were not altered by the adjacent insertions of the TEVP sites, the corresponding caspase-3 sites are no longer cleavable by that enzyme, as demonstrated by the maintenance of intact DFF45 I1I2 mutant protein after caspase-3 treatment, as revealed by western blotting (Figure 1E, lane 8), and by the inability of caspase-3 alone to activate the nuclease (Figure 1F, lanes 2–4). We conclude that the ability of caspase-3 to cleave at these sites is dependent on the amino acid sequence context and that the additional seven amino acids may affect the spatial properties of the caspase-3 cleavage sites. As shown in Figure 1F (lane 8), only the heterodimer containing the double-TEVP-site-insertion mutant I1I2 could be activated by TEVP treatment alone to a specific activity nearly equal to that of the caspase-3 ± TEVP treated wild-type enzyme (Figure 1F, lanes 1 and 9). We conclude that a novel modified form of mouse DFF nuclease (DFF-T) has been successfully generated, expressed and purified, whose activation is specifically under the control of TEVP.

Co-expression of TEVP and DFF-T in S. cerevisiae
We intended to develop a highly reproducible system in yeast for the regulated expression and activation of DFF-T for the purposes of in vivo footprinting of the positions of nucleosomes and transcription factors on specific genes. Previously, Simpson and Wang (38) were successful in developing a DNase I expression system in yeast for in vivo footprinting experiments by putting the DNase I gene into a high copy shuttle expression vector under the control of the GAL1 promoter. Here we have taken advantage of a system developed by Nasmyth and co-workers (28), who engineered the TEVP gene's coding region by adding SV40 nuclear localization signals to its N- and C-termini, which was placed under the control of the GAL1 promoter, and integrated into the trp1 locus. We therefore created a yeast strain with a galactose-inducible TEVP gene. We next inserted various engineered forms of mouse DFF45 and mouse DFF40 genes into the bicistronic, high copy number shuttle expression vector pESC-HIS (Stratagene), which divergently expresses introduced sequences from GAL1-10 promoters, and transformed yeast strains that either lacked or possessed the TEVP gene under GAL control with these expression vectors, and optimized expression in this system by titration with different concentrations 3-amino-1,2,4-triazole. As shown by the plating assay in Figure 2A, expression of TEVP together with various engineered forms of mouse DFF results in cell death only when the DFF45 I1I2 mutant and DFF40 are co-expressed together with TEVP. It is significant that this in vivo result is in agreement with the in vitro activation data for the corresponding recombinant proteins expressed in E. coli (Figure 1F above). Furthermore, yeast DNA undergoes nucleosomal laddering in vivo in a galactose-dependent fashion, only in the strain harboring the genes encoding the DFF45 I1I2 mutant, DFF40 and TEVP (Figure 2B, lane 8). We conclude that this form of DFF expression could be useful as a genomics tool to study yeast chromatin structure in vivo. It should be noted, however, just as in the case of the DNase I yeast expression system developed by Simpson and Wang (38), there is ca. 6-h time lag after GAL induction before significant DNA breakdown occurs, and it would be most desirable to be able to much more rapidly activate the nuclease to obtain a snapshot of the in vivo chromatin structure. This might be achieved by the high-level constitutive expression of codon-optimized DFF-T prior to GAL induction of TEVP. In addition, it may be possible to engineer TEVP for rapid regulated transport from the cytoplasm to the nucleus. A further limitation of DFF, particularly in the yeast system, is that these cells have a very high RNA/DNA ratio and RNA is an inhibitor of the enzyme (37).

Creation of synthetic DFF genes and their high-level expression in E. coli
Many codons in DFF cDNAs are rare with respect to their cognate tRNA abundances in E. coli, and only a few micrograms of recombinant proteins are routinely obtained upon expression of recombinant forms of DFF in this organism per liter of culture. To provide a more robust source of DFF proteins to the scientific community we have created codon-optimized synthetic genes for wild-type and I1I2 mutants of the mouse and human DFF proteins through their robotic synthesis from pairs of overlapping 40-mer oligonucleotides (36). After expression of the proteins encoded by these synthetic genes in the pETDuet™ E. coli vector (Novagen), more than 20% of the total E. coli protein corresponds to DFF bands in Coomassie blue-stained SDS–PAGE gels (Figure 3A). This level of expression is highly significant because our previous expression systems using the corresponding wild-type cDNA coding sequences gave no visible new bands after induction in such gels of total E. coli cell protein (data not shown). Furthermore, DFF nuclease activities produced from these synthetic genes were fully dependent on cleavage by the appropriate protease, and both wild-type and insertion mutant proteins have similar nuclease activities (Figure 3B).
Figure 3. High-level expression from synthetic human DFF genes in E. coli. (A) Coomassie blue-stained SDS–PAGE gel of total cell protein from uninduced or induced E. coli BL21 (DE3) transformants, both carrying DFF40 synthetic genes, and either DFF45 wild-type (DFF-wt) or the DFF45I1I2 mutant (DFF-T) synthetic genes, in the pETDuet™ expression plasmid. (B) Agarose gel of plasmid DNA substrate incubated with the indicated proteinase-treated DFF nucleases.



Mapping hypersensitive sites and nucleosome positions on the inactive and active yeast PHO5 gene with DFF-T produced from synthetic genes
We have demonstrated here that DFF-T could be fully and specifically activated by TEVP both in vitro and in vivo. To further investigate the utility of DFF-T we mapped nucleosome positions and hypersensitive sites within the promoter region of PHO5 gene, one of the most thoroughly studied yeast genes with respect to chromatin structure (29–32). Upon induction of PHO5 gene transcription by phosphate starvation, four nucleosomes are displaced from the upstream promoter region through the binding of Pho4p to UASp1 and UASp2 and the recruitment of chromatin remodeling complexes (Figure 4, right diagram). To evaluate the effectiveness of DFF-T to detect hypersensitive sites, and both nucleosome positioning and displacement, we made a direct comparison on the same chromatin samples with MNase cutting patterns by indirect end-labeling analysis. Here we utilized human DFF-T produced in high-yield from codon-optimized synthetic genes in an E. coli expression system (Figure 3). This comparison reveals a striking degree of similarity with respect to: (i) the positions of hypersensitive sites HS2 and HS3 on the uninduced PHO5 gene, which correspond to the accessible UASp1 between nucleosomes −2 and −3, and the 3′ end of the PHO5 gene, respectively (29,30); (ii) the positions of nucleosome footprints (Figure 4, compare lanes 1 and 4) and (iii) in the displacement of nucleosomes −1 to −4 after gene induction (Figure 4, compare lanes 2 and 5). The partial occupancy by nucleosomes at the −1 position of the activated PHO5 promoter may be attributed to a steady state of disassembly and reassembly of nucleosomes as previously described (39). There is some subtle difference, however, in the hypersensitive sites in the HS1 doublet (Figure 4, compare lanes 1 and 2 with lanes 4 and 5), which corresponds to the upstream region of the YBR094W gene. In summary, this comparison allows us to conclude that DFF-T is an excellent reagent to map the chromatin structures associated with specific inactive or active genes. We speculate that this enzyme may detect chromatin structures missed by other conventional enzymes.
Figure 4. Comparison between DFF-T and MNase in revealing specific chromatin structures of the yeast PHO5 gene. Yeast were grown in the absence or presence of inorganic phosphate to induce or repress the PHO5 gene, respectively, spheroplasts were isolated upon Zymolase treatment and then chromatin or purified naked DNA were digested with TEVP-treated human DFF-T or MNase as indicated. DNA was purified, digested with ApaI, electrophorectically separated on a 1.6% agarose gel, and the resulting Southern blot was hybridized with a 32P-labeled probe. Arrowheads and arrows indicate the positions of DNA length markers and nuclease hypersensitive sites HS1–3, respectively. The diagram on the right depicts as gray ovals the locations of positioned nucleosomes in the upstream and coding regions of the PHO5 gene, as closed circles the positions of the TATA-box and the Pho4-binding sites at UASp1 and UASp2, and as a bent arrow the transcription initiation site.



Other potential uses for DFF in functional genomics
In this study, we have shown that DFF-T is an excellent reagent for chromatin structure investigations. The enzyme should also prove to be valuable in other types of footprinting experiments. From our previous and current studies, we also know DFF is extremely suitable for fragmenting chromatin to prepare nucleosomes without them possessing internal DNA nicks. We also propose that DFF nuclease is ideally suited to serve as a substitute for sonication to shear chromatin to nucleosome-sized fragments for the chromatin immunoprecipitation (ChIP) technique, because it only cuts between and not within nucleosomes and thus it cannot over-digest the chromatin DNA as other nucleases can. This nuclease should also be ideal for the purpose of generating genomic libraries for gene cloning/subcloning and shotgun sequencing, as it creates nearly exclusively double-stranded blunt DNA ends, and leaves 5′-phosphate and 3′-hydroxyl groups that are ideal for blunt-end cloning by ligation with T4 DNA ligase. Controlled digestion of DNA to yield fragments of various sizes should be easy to achieve with this enzyme. Thus, DFF-T should be a valuable tool for several lines of investigation.

ACKNOWLEDGEMENTS
This work was supported in part by Grant N30105831/1763 from the Polish Ministry of Scientific Research (to P.W.), Grant RO1-GM29935 from the National Institutes of Health and Grant I-0823 from the Robert A. Welch Foundation (to W.T.G.). Funding to pay the Open Access publication charges for this article was provided by Grant RO1-AI067906 from the National Institutes of Health (to W.T.G.).

Conflict of interest statement. None declared.
==== Refs
REFERENCES
1 van Holde KE   Chromatin 1988 Berlin Springer 
2 Mellor J   Dynamic nucleosomes and gene transcription Trends Genet 2006 22 320 329 16631276 
3 Dingwall C  Lomonossoff GP  Laskey RA   High sequence specificity of micrococcal nuclease Nucleic Acids Res 1981 9 2659 2673 6269057 
4 Horz W  Altenburger W   Sequence specific cleavage of DNA by micrococcal nuclease Nucleic Acids Res 1981 9 2643 2658 7279658 
5 Nelson PP  Albright SC  Garrard WT   Nucleosome arrangement with regard to DNA base composition J. Biol. Chem 1979 254 9194 9199 479188 
6 Wyllie AH   Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation Nature 1980 284 555 556 6245367 
7 Enari M  Sakahira H  Yokoyama H  Okawa K  Iwamatsu A  Nagata S   A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD Nature 1998 391 43 50 9422506 
8 Halenbeck R  MacDonald H  Roulston A  Chen TT  Conroy L  Williams LT   CPAN, a human nuclease regulated by the caspase-sensitive inhibitor DFF45 Curr. Biol 1998 8 537 540 9560346 
9 Liu X  Li P  Widlak P  Zou H  Luo X  Garrard WT  Wang X   The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis Proc. Natl Acad. Sci. USA 1998 95 8461 8466 9671700 
10 Widlak P  Garrard WT   Discovery, regulation, and action of the major apoptotic nucleases DFF40/CAD and endonuclease G J. Cell. Biochem 2005 94 1078 1087 15723341 
11 Liu X  Zou H  Slaughter C  Wang X   DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis Cell 1997 89 175 184 9108473 
12 Sakahira H  Enari M  Nagata S   Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis Nature 1998 391 96 99 9422513 
13 Widlak P  Lanuszewska J  Cary RB  Garrard WT   Subunit structures and stoichiometries of human DNA fragmentation factor proteins before and after induction of apoptosis J. Biol. Chem 2003 278 26915 26922 12748178 
14 Samejima K  Earnshaw WC   ICAD/DFF regulator of apoptotic nuclease is nuclear Exp. Cell Res 1998 243 453 459 9743604 
15 Samejima K  Earnshaw WC   Differential localization of ICAD-L and ICAD-S in cells due to removal of a C-terminal NLS from ICAD-L by alternative splicing Exp. Cell Res 2000 255 314 320 10694446 
16 Lechardeur D  Drzymala L  Sharma M  Zylka D  Kinach R  Pacia J  Hicks C  Usmani N  Rommens JM    Determinants of the nuclear localization of the heterodimeric DNA fragmentation factor (ICAD/CAD) J. Cell Biol 2000 150 321 334 10908575 
17 Liu X  Zou H  Widlak P  Garrard W  Wang X   Activation of the apoptotic endonuclease DFF40 (caspase-activated DNase or nuclease). Oligomerization and direct interaction with histone H1 J. Biol. Chem 1999 274 13836 13840 10318789 
18 Woo EJ  Kim YG  Kim MS  Han WD  Shin S  Robinson H  Park SY  Oh BH   Structural mechanism for inactivation and activation of CAD/DFF40 in the apoptotic pathway Mol. Cell 2004 14 531 539 15149602 
19 Widlak P  Li P  Wang X  Garrard WT   Cleavage preferences of the apoptotic endonuclease DFF40 (caspase-activated DNase or nuclease) on naked DNA and chromatin substrates J. Biol. Chem 2000 275 8226 8232 10713148 
20 Widlak P  Garrard WT   Ionic and cofactor requirements for the activity of the apoptotic endonuclease DFF40/CAD Mol. Cell. Biochem 2001 218 125 130 11330826 
21 Widlak P  Li LY  Wang X  Garrard WT   Action of recombinant human apoptotic endonuclease G on naked DNA and chromatin substrates: cooperation with exonuclease and DNase I J. Biol. Chem 2001 276 48404 48409 11606588 
22 Widlak P  Palyvoda O  Kumala S  Garrard WT   Modeling apoptotic chromatin condensation in normal cell nuclei. Requirement for intranuclear mobility and actin involvement J. Biol. Chem 2002 277 21683 21690 11927586 
23 Widlak P  Garrard WT   Unique features of the apoptotic endonuclease DFF40/CAD relative to micrococcal nuclease as a structural probe for chromatin Biochem. Cell. Biol 2006 84 405 410 16936813 
24 Lee AY  Park BC  Jang M  Cho S  Lee DH  Lee SC  Myung PK  Park SG   Identification of caspase-3 degradome by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionization-time of flight analysis Proteomics 2004 4 3429 3436 15468300 
25 Dougherty WG  Cary SM  Parks TD   Molecular genetic analysis of a plant virus polyprotein cleavage site: a model Virology 1989 171 356 364 2669323 
26 Smith TA  Kohorn BD   Direct selection for sequences encoding proteases of known specificity Proc. Natl Acad. Sci. USA 1991 88 5159 5162 2052595 
27 Kang JJ  Schaber MD  Srinivasula SM  Alnemri ES  Litwack G  Hall DJ  Bjornsti MA   Cascades of mammalian caspase activation in the yeast Saccharomyces cerevisiae J. Biol. Chem 1999 274 3189 3198 9915859 
28 Uhlmann F  Wernic D  Poupart MA  Koonin EV  Nasmyth K   Cleavage of cohesin by the CD clan protease separin triggers anaphase in yeast Cell 2000 103 375 386 11081625 
29 Almer A  Horz W   Nuclease hypersensitive regions with adjacent positioned nucleosomes mark the gene boundaries of the PHO5/PHO3 locus in yeast EMBO J 1986 5 2681 2687 3023055 
30 Almer A  Rudolph H  Hinnen A  Horz W   Removal of positioned nucleosomes from the yeast PHO5 promoter upon PHO5 induction releases additional upstream activating DNA elements EMBO J 1986 5 2689 2696 3536481 
31 Boeger H  Griesenbeck J  Strattan JS  Kornberg RD   Removal of promoter nucleosomes by disassembly rather than sliding in vivo Mol. Cell 2004 14 667 673 15175161 
32 Adkins MW  Howar SR  Tyler JK   Chromatin disassembly mediated by the histone chaperone Asf1 is essential for transcriptional activation of the yeast PHO5 and PHO8 genes Mol. Cell 2004 14 657 666 15175160 
33 Jessen WJ  Hoose SA  Kilgore JA  Kladde MP   Active PHO5 chromatin encompasses variable numbers of nucleosomes at individual promoters Nat. Struct. Mol. Biol 2006 13 256 263 16491089 
34 Korn C  Scholz SR  Gimadutdinow O  Pingoud A  Meiss G   Involvement of conserved histidine, lysine and tyrosine residues in the mechanism of DNA cleavage by the caspase-3 activated DNase CAD Nucleic Acids Res 2002 30 1325 1332 11884629 
35 Lee MS  Garrard WT   Transcription-induced nucleosome ‘splitting’: an underlying structure for DNase I sensitive chromatin EMBO J 1991 10 607 615 2001676 
36 Chambers RS  Johnston SA   High-level generation of polyclonal antibodies by genetic immunization Nat. Biotechnol 2003 21 1088 1092 12910245 
37 Widlak P  Garrard WT   The apoptotic endonuclease DFF40/CAD is inhibited by RNA, heparin and other polyanions Apoptosis 2006 11 1331 1337 16699957 
38 Wang X  Simpson RT   Chromatin structure mapping in Saccharomyces cerevisiae in vivo with DNase I Nucleic Acids Res 2001 29 1943 1950 11328878 
39 Boeger H  Griesenbeck J  Strattan JS  Kornberg RD   Nucleosomes unfold completely at a transcriptionally active promoter Mol. Cell 2003 11 1587 1598 12820971

